Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.

Q-Sera CEO Michael Grant added, “Japan has a history of innovation in blood collection tubes with Terumo Corporation a leader in this sector, and we are delighted to have achieved our first commercial ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

For patients who experience excessive bleeding during cardiac surgery, four-factor prothrombin complex concentrate (4F-PCC), a blood product that contains clotting factors, is significantly more ...

PARAMUS, N.J., April 2, 2025 /PRNewswire/ -- Octapharma USA announced the Journal of the American Medical Association (JAMA) has published results from a Phase III clinical trial, which observed ...

About The Study: In this unblinded randomized clinical trial, prothrombin complex concentrate had superior hemostatic efficacy and safety advantages to frozen plasma among patients requiring ...

Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...

Biosensor Research Group, Institute of Clinical and Experimental Transfusion Medicine, University Hospital of Tübingen, Germany, Department of Thoracic, Cardiac and Vascular Surgery, University of ...

Antiphospholipid syndrome (APS) is characterised by arterial and/or venous thrombosis and recurrent fetal loss in association with the presence of antiphospholipid antibodies (aPL). In addition to β 2 ...